Evidence map›Paper›PMID 30214610›Full record

ArticleOncology letters2018

Evaluation of the mRNA expression levels of integrins α3, α5, β1 and β6 as tumor biomarkers of oral squamous cell carcinoma.

Hsueh-Wei Chang, Ching-Yu Yen, Chung-Ho Chen, Jun-Hsu Tsai, Jen-Yang Tang, Yung-Ting Chang, Yu-Hsun Kao, Yen-Yun Wang, Shyng-Shiou F Yuan, Sheng-Yang Lee

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Antioxidants (Basel, Switzerland) · 2021
    Article
  12. Journal of personalized medicine · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Combined Treatment with Low Cytotoxic Ethyl AcetateAntioxidants (Basel, Switzerland) · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Hsueh-Wei ChangDepartment of Biomedical Sciences and Environmental Biology, Kaohsiung Medical University, Kaohsiung 80708, Taiwan, R.O.C.
Ching-Yu YenDepartment of Oral and Maxillofacial Surgery, Chi-Mei Medical Center, Tainan 71004, Taiwan, R.O.C.
Chung-Ho ChenDepartment of Dentistry, Kaohsiung Municipal Hsiao Kang Hospital, Kaohsiung 81267, Taiwan, R.O.C.
Jun-Hsu TsaiDepartment of Oral and Maxillofacial Surgery, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan, R.O.C.
Jen-Yang TangDepartment of Radiation Oncology, Faculty of Medicine, College of Medicine, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan, R.O.C.
Yung-Ting ChangDoctoral Degree Program in Marine Biotechnology, National Sun Yat-sen University, Kaohsiung 80424, Taiwan, R.O.C.
Yu-Hsun KaoDepartment of Oral and Maxillofacial Surgery, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan, R.O.C.
Yen-Yun WangSchool of Dentistry, College of Dental Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan, R.O.C.
Shyng-Shiou F YuanCancer Center, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan, R.O.C.
Sheng-Yang LeeSchool of Dentistry, Taipei Medical University, Taipei 11031, Taiwan, R.O.C.
Kaohsiung Medical University · TWChi Mei Medical Center · TWKaohsiung Municipal Hsiao-Kang Hospital · TWNational Sun Yat-sen University · TWTaipei Medical University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Integrin signaling may modulate several different functions involved in cell migration, invasion, proliferation and motility, and is a potential candidate biomarker for oral cancer. In the present study, a total of four integrin genes were evaluated as potential biomarkers of oral squamous cell carcinoma (OSCC). Gene expression was determined using the reverse transcription-quantitative polymerase chain reaction in 55 OSCC and 55 matched normal oral tissues. The performance of individual and combined biomarkers was analyzed by receiver operating characteristic (ROC) analysis based on the relative mRNA expression (OSCC vs. matched oral tissue from the tumor-free margin), which was calculated using the ΔΔCq value (ΔCq of OSCC-ΔCq of oral tissue from the tumor-free margin of the same patient). In the individual ROC analysis, the areas under the ROC curve (AUCs) of relative mRNA expression (ΔΔCq) of integrin subunit α3 (ITGA3), integrin subunit α5 (ITGA5), integrin subunit β1 (ITGB1) and integrin subunit β6 (ITGB6) in all tumor locations were 0.724, 0.698, 0.640 and 0.657, respectively. For locations 2 (tongue/mouth part) and 3 (edentulous ridge), their individual AUC values were 0.840, 0.765, 0.725 and 0.763, respectively. In the cumulative ROC analysis, ITGA3, ITGA5 and ITGB1 genes exhibited the highest combined AUC values (0.809 and 0.871 for all locations and locations 2 and 3 combined, respectively) compared with other biomarker combinations. In conclusion, the results of the present study identified that higher mRNA expressions of ITGA3, ITGA5, ITGB1 and ITGB6 genes are suitable for OSCC diagnosis biomarkers. Cumulative ROC analysis indicated an improved overall performance compared with the best individual integrin biomarker of OSCC.

Indexed as

integrinoral cancerreceiver-operating characteristic curvestumor biomarker

Identifiers

PMID30214610
PMCPMC6126156
OpenAlexW2884485841

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.